CCI Clears Rasmalai Stake Buy in Yatharth Hospital Chain

A hospital chain has cleared its competition hurdle. On 14 November 2026 the Competition Commission of India (CCI) approved the acquisition of certain shareholding of Yatharth Hospital & Trauma Care Services Limited by Rasmalai Limited. In the language of competition law the transaction is a proposed combination, and the two sides are described as the acquirer and the target.

Who is buying

The acquirer, Rasmalai Limited, is an entity incorporated in Cyprus whose principal activity is holding investments. The Commission's note records that it has no activities and no presence in India at present. Control over it is indirect: the entity is controlled by investment funds that are managed or advised by Advent International, L.P. and its affiliates. In other words, a global private equity platform is coming into an Indian hospital company through a holding vehicle registered abroad.

Who is being bought into

The target, Yatharth Hospital & Trauma Care Services Limited, runs a network of super-specialty hospitals in India. Its services span comprehensive healthcare, diagnostics and advanced medical procedures across several specialties, which places the deal in the hospital and diagnostics segment of the healthcare market.

What the approval means

The CCI is the statutory authority that regulates competition in India, and a combination of this size must be notified to it and cleared before it can be completed. The Commission examines whether a transaction is likely to cause an appreciable adverse effect on competition in the relevant market; where it finds none, it approves the deal. A detailed order follows the announcement of approval, and the clearance announced on this date lets the parties proceed with the share purchase.

Why it matters for the exam

Questions on this kind of news usually ask three things: which regulator gave the approval, who the acquirer and the target are, and where the acquirer is registered. Remember that the regulator here is the CCI and not a securities, banking or insurance regulator, that the acquirer is incorporated in Cyprus and backed by funds linked to Advent International, and that the target operates super-specialty hospitals in India.